NCT03407105 - A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 21, 2003

Primary Completion Date

February 21, 2006

Study Completion Date

February 21, 2006

Conditions

Human Immunodeficiency Virus (HIV)

Interventions

BIOLOGICAL

MDX-010

Specified dose on specified days

Trial Locations (5)

Orlando Immunology Center, Orlando

Care Resource, Miami

Shannon Schrader, MD, Houston

Tower ID Medical Associates, Los Angeles

Quest Clinical Research, San Francisco